Home / Market News / $MMED
benzinga Corporate Catalyst Impact 55/100 ● neutral

Jefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

Oct 12, 2026, 12:04 PM UTC · Primary ticker $MMED

Jefferies has initiated coverage on Minimed Group (MMED) with a 'Hold' rating and a $22 price target. This analyst coverage provides a new valuation perspective for investors but is not a major catalyst given the neutral rating.

Jefferies analyst Michael Toomey has initiated coverage on Minimed Group (MMED) with a 'Hold' rating and a $22 price target. This event provides the market with a new professional assessment of the company's prospects and valuation. For MMED, this is a neutral development as a 'Hold' rating suggests that the analyst believes the stock is fairly valued at its current price, offering limited upside or downside in the short term. Investors will now factor this new price target into their own valuation models, potentially influencing trading activity. The long-term implications depend on whether future analyst reports or company performance align with or deviate from this initial assessment. A key risk for traders is that the 'Hold' rating might not provide a strong catalyst for price movement, potentially leading to sideways trading in the near term.

$MMED neutral New analyst coverage with a 'Hold' rating and price target.
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.